Analysen von Mark Purcell
| 06.01.20 | Novartis verkaufen | Morgan Stanley | |
| 06.01.20 | Novo Nordisk neutral | Morgan Stanley | |
| 06.01.20 | AstraZeneca neutral | Morgan Stanley | |
| 06.01.20 | Roche overweight | Morgan Stanley | |
| 06.01.20 | Sanofi overweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 21.10.19 | Novartis Underweight | Morgan Stanley | |
| 17.10.19 | Roche overweight | Morgan Stanley | |
|
Werbung
|
|||
| 16.10.19 | Roche overweight | Morgan Stanley | |
| 30.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 27.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 23.09.19 | Sanofi overweight | Morgan Stanley | |
| 06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 17.06.19 | GSK Underweight | Morgan Stanley | |
| 30.05.19 | Novartis Underweight | Morgan Stanley | |
| 07.05.19 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 30.04.19 | Roche overweight | Morgan Stanley | |
| 10.04.19 | Novartis Underweight | Morgan Stanley | |
| 11.02.19 | Roche overweight | Morgan Stanley | |
| 14.12.18 | GSK Underweight | Morgan Stanley | |
| 14.12.18 | Merck Equal-Weight | Morgan Stanley | |
| 14.12.18 | Sanofi Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 14.12.18 | Novartis Equal-Weight | Morgan Stanley | |
| 14.12.18 | Roche overweight | Morgan Stanley | |
| 19.01.16 | AstraZeneca Equal weight | Barclays Capital | |
| 29.07.15 | Bayer Underweight | Barclays Capital | |
| 05.05.15 | GSK overweight | Barclays Capital | |
| 01.04.15 | AstraZeneca Underweight | Barclays Capital | |
| 01.04.15 | GSK overweight | Barclays Capital | |
| 01.04.15 | Novartis Equal weight | Barclays Capital | |
| 01.04.15 | Roche overweight | Barclays Capital | |
| 01.04.15 | Sanofi Equal weight | Barclays Capital | |
| 01.04.15 | Merck Equal weight | Barclays Capital | |
| 01.04.15 | Bayer Underweight | Barclays Capital | |
| 16.01.15 | GSK kaufen | Barclays Capital | |
| 16.01.15 | Roche overweight | Barclays Capital | |
| 16.01.15 | AstraZeneca Underweight | Barclays Capital | |
| 16.01.15 | Sanofi Equal weight | Barclays Capital | |
| 16.01.15 | Bayer Underweight | Barclays Capital | |
| 16.01.15 | Merck Equal weight | Barclays Capital | |
| 16.10.14 | STADA Underweight | Barclays Capital | |
| 16.10.14 | Merck Underweight | Barclays Capital | |
| 16.10.14 | Bayer Equal weight | Barclays Capital | |
| 16.10.14 | AstraZeneca neutral | Barclays Capital | |
| 16.10.14 | GSK neutral | Barclays Capital | |
| 16.10.14 | Novartis Equal weight | Barclays Capital | |
| 16.10.14 | Sanofi overweight | Barclays Capital | |
| 15.10.14 | Roche overweight | Barclays Capital | |